Bispecific Monoclonal Antibodies and CAR T-Cell Therapy in Multiple Myeloma, Omar Nadeem, MD

1 Views
administrator
administrator
07/14/23

In this presentation, Omar Nadeem, MD considers the role of bispecific antibodies and CAR T-cell therapy in multiple myeloma treatment. Presented at the 2022 Dana-Farber Cancer Institute Multiple Myeloma Patient Education Symposium. For more information, visit: https://www.dana-farber.org/mu....ltiple-myeloma-progr

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next